🎉 Celebrating 7 Years of Phortas! 🎉 Today marks a special milestone for us at Phortas – we’re celebrating 7 years of dedication, growth, and success in the world of Regulatory Affairs and Drug Development! From humble beginnings to becoming a trusted partner in the pharmaceutical industry, our journey has been defined by innovation, collaboration, and an unwavering commitment to delivering exceptional regulatory solutions. A heartfelt thank you to our amazing clients, partners, and the Phortas team for your support and trust over the years. Your dedication has been instrumental in our growth and success. Here’s to many more years of advancing health, driving excellence, and making a lasting impact! 🚀 #Anniversary #7YearsOfSuccess #Phortas #RegulatoryAffairs #DrugDevelopment #Innovation #Collaboration #ThankYou #Pharma #biotech
Phortas
Arzneimittelherstellung
Aachen, Germany 441 Follower:innen
Regulatory Affairs and Drug Development Consulting
Info
Phortas provides a world-class product development support. Phortas is uniquely positioned to provide you access to the best expertise and to ensure you meet all requirements while developing your products. At Phortas we support your development programs by the core competencies that define our success: ***World-class expertise: Our experts are established professionals in their field and truly dedicated to assigned projects ***Fast acting: We can define the project scope and provide our support immediately ***Flexibility: We support our clients in ad-hoc, short-term or long-term projects, using a staggered approach in addressing all client needs Interested to work with us? Contact us at: [email protected] 49 (0) 241 942 69 101
- Website
-
http://www.phortas.com
Externer Link zu Phortas
- Branche
- Arzneimittelherstellung
- Größe
- 2–10 Beschäftigte
- Hauptsitz
- Aachen, Germany
- Art
- Privatunternehmen
- Gegründet
- 2017
- Spezialgebiete
- Pharmaceutical Consulting, Pharmaceutical Experts, Pharmaceuticals, Pharmaceutical Industry, Regulatory Affairs, Clinical Management, Development Consulting, Consulting und Drug Development
Orte
-
Primär
Mariahilfstr. 16
Aachen, Germany 52062, DE
Beschäftigte von Phortas
-
Danilo Uvalin PMP, RAC
Clinical Development Professional, Head Development Services @ Phortas
-
Jasmina Savic
Founder and Managing Director at Phortas GmbH
-
Irena Milobratovic
Principal Consultant | Regulatory • Quality • R&D | Inspiriting advances in life science 🌍
-
Dr. Darius-Jean Namdjou
Director, Senior Regulatory Lead at Phortas
Updates
-
📢 Exciting News! Phortas’ Director and Senior Regulatory Lead, Dr. Darius-Jean Namdjou, will be attending the World Drug Safety Congress Europe 2024 in Amsterdam from October 9-10. We are thrilled to participate in this leading event and look forward to connecting with our colleagues and all professionals passionate about advancing drug safety. We are also happy to discuss any Regulatory Affairs and Drug Development topics with you. 🗓️Let’s Connect! Don’t miss the opportunity to meet us at the congress—drop by and say hello, or reach out to schedule a meeting. info➡️ https://lnkd.in/gj8-pf6 #DrugSafety #WorldDrugSafetyCongress #RegulatoryAffairs #Phortas #Networking #biotech #pharmaceutical
-
🌟 Exciting News from Phortas! 🌟 We are thrilled to announce that our Managing Director, Jasmina Savic, has been selected to serve on the Regulatory Affairs Professionals Society (RAPS) Euro Convergence Program Committee for a three-year term, with a key focus on the Pharmaceutical track development. 🎯 Her dedication and leadership will undoubtedly contribute to shaping the future of regulatory affairs in the pharmaceutical industry. Congratulations, Jasmina! We are proud of your achievement! 👏 #Leadership #Pharmaceuticals #RegulatoryAffairs #RAPS #EuroConvergence #Phortas
-
Phortas: Your Trusted Partner for CTIS Submission in the EU Phortas is uniquely positioned to support your CTIS submission in the EU. Our team of international regulatory experts brings extensive experience in handling regulatory submissions of all kinds, including orphan drugs, and clinical trials ranging from single-country to multi-country studies, across Phase I-IV. What sets Phortas apart? We are a customer-centric consultancy, specifically tailored to the needs of small to mid-sized (bio)pharma companies. Our validated processes, SOPs, and work instructions ensure a seamless and compliant submission process. From the very first kick-off meeting through to submission and follow-up, Phortas works closely with sponsors, providing transparent oversight and regular progress updates. With Phortas, you gain a partner dedicated to guiding you through every step of the regulatory journey. Contact us: [email protected] #regulatoryaffairs #drugdevelopment #biotech #pharmaceutical #ctis
-
Case Study: How Phortas Helped US-Based Biotech Secure ODD in the EU 🧬 When a U.S.-based company needed to accelerate the approval process for a new drug targeting a rare disease, they turned to Phortas for support in Europe. While they had already secured Orphan Drug Designation (ODD) in the USA, the complex European regulations presented a new challenge. See below how Phortas with its SME status helped with ODD and supported a development of a ground breaking stem cells orphan drug. #regulatoryaffairs #drugdevelopment #odd #raredisease #orphandrugs #biotech
-
Phortas hat dies direkt geteilt
☀️ As the summer holiday season heats up, it's the perfect time to take a break from the beach reads and dive into something just as refreshing—cutting-edge insights from the EMA Big Data Steering Group Workshop! At Phortas, we had the privilege of attending this influential event, where industry leaders and experts shared perspectives on the future of real-world evidence data in healthcare. Read more here: https://lnkd.in/ew3_XQri #regulatoryaffairs #phortas #rwe #rwd
-
☀️ As the summer holiday season heats up, it's the perfect time to take a break from the beach reads and dive into something just as refreshing—cutting-edge insights from the EMA Big Data Steering Group Workshop! At Phortas, we had the privilege of attending this influential event, where industry leaders and experts shared perspectives on the future of real-world evidence data in healthcare. Read more here: https://lnkd.in/ew3_XQri #regulatoryaffairs #phortas #rwe #rwd
Insights from the EMA Big Data Steering Group Workshop
phortas.com
-
📣 We are proud to announce that Dr. Darius-Jean Namdjou, our Director, Senior Regulatory Lead at Phortas will be presenting at 'Clinical Partnership and Outsourcing' conference in London, from 08-09 Oct 2024. This opportunity highlights our commitment to excellence and our dedication to advancing industry standards through knowledge sharing and collaboration. #regulatoryaffairs #biotech #drugdevelopment
Time's running out to secure your place at Clinical Partnerships and Outsourcing at the lowest available rate! Taking place on 8-9 October 2024 in London, this event will help you: - Understand how to build more effective stakeholder relationships, optimise your clinical partnerships and meet your objectives - Increase operational momentum through better forecasting and contingency planning - Unlock innovative outsourcing strategies that will help you minimise expenses and maximise clinical outcomes Don't miss the opportunity to hear from the industry's top collaborators and gain leading advice from: - Joanne Brown, Country Head Portfolio, Study & Site Operations - GCO – GDD, Novartis - Andre Krzeminski, General Practitioner, Albany House Medical Centre - Angela May, Senior Director/Head DCT Strategy & Implementation, Clinical Operations, Bayer - Dr. Darius-Jean Namdjou, Director, Senior Regulatory Lead, Phortas - piet theisohn, VP, Clinical Development & Operations, Bayer - Saskia van Dalen, Global Head R&D Procurement, Sandoz - Antoine Vigneau, Senior Director, Biosamples Head of Alliances and Technology, AstraZeneca And many more! Register before midnight TONIGHT to save up to £800! 👉 Book now to save! https://bit.ly/3XvlpWo 📅 Download the agenda to learn more: https://bit.ly/4b2QVhq #ClinicalPartnerships #ClinicalOutsourcing #ClinicalResearch #ClinicalTrials #ClinicalCollaboration
-
Phortas hat dies direkt geteilt
🗨 𝗧𝗲𝘀𝘁𝗶𝗺𝗼𝗻𝗶𝗮𝗹 𝗧𝘂𝗲𝘀𝗱𝗮𝘆 EU-X-CT thrives because of our passionate volunteers. Their commitment drives our mission to improve cross-border access to clinical trials Thank you Dr. Darius-Jean Namdjou for your involvement in the EU-X-CT project. 🔗 𝗠𝗼𝗿𝗲 𝗮𝗯𝗼𝘂𝘁 𝗘𝗨-𝗫-𝗖𝗧: https://eu-x-ct.eu/ #TestimonialTuesday #EUXCT #CrossBorderTrials #ClinicalTrials
-
Phortas is growing! We are excited to announce a new entry-level position in our Regulatory Affairs department! No previous industry experience is required—bring your passion for the pharmaceutical Regulatory Affairs field and eagerness to learn, and we'll provide the rest. Apply here: https://lnkd.in/dvmmM3G #regulatoryaffairs #job #pharmaceuticalindustry #biotech